Literature DB >> 12067313

The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.

D I Mitsias1, A G Tzioufas, C Veiopoulou, E Zintzaras, I K Tassios, O Kogopoulou, H M Moutsopoulos, G Thyphronitis.   

Abstract

Expression of type-1 and type-2 cytokines at the mRNA level in labial salivary glands (LSG) of patients with Sjogren's syndrome (SS), as reported by several groups, have generated conflicting results. In the present study we have directly examined the production of IL-4, IL-13 and IFN-gamma by lymphocytes infiltrating the LSG of 44 consecutive patients referred for SS evaluation. Cytokines production was evaluated following in vitro culture of LSG in the presence of IL-2. IFN-gamma and IL-13 were detected in the majority of SN (24/44 and 26/44, respectively) while IL-4 was present in 5/44 SN. The presence of IFN-gamma was significantly higher in SS patients, as opposed to patients who did not fulfil the criteria for SS (P < 0.01). In addition, almost all cultured lymphocytes expressed mRNA for IFN-gamma (17/19 cultures) and IL-13 (18/19) while IL-4 mRNA was also expressed at high frequency (14/19 cultures). Interestingly, the IFN-gamma mRNA copies in cultured lymphocytes correlated significantly with the intensity of lymphocytic infiltration as evaluated by Chisholm's score (P < 0.01). Furthermore, RT-PCR of RNA extracted from whole LSG from 14 SS patients also demonstrated the presence of all cytokines in the majority of the cases and the prevalence of IFN-gamma in LSG with high-grade infiltration. Because IL-13 was produced by the majority of the cultured LSG, IgE production was also evaluated. Interestingly, IgE was detected in 21/44 LSG culture SN and mainly in those biopsies that had Chisholm's score less than 0.5 (P < 0.05). We conclude that lymphocytes infiltrating the LSG are capable of producing both Th1 and Th2 cytokines and that the balance between them shifts in favour of Th1 in LSG with high infiltration score and in patients with SS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067313      PMCID: PMC1906267          DOI: 10.1046/j.1365-2249.2002.01869.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.

Authors:  E C Kolkowski; P Reth; F Pelusa; J Bosch; R Pujol-Borrell; J Coll; D Jaraquemada
Journal:  J Autoimmun       Date:  1999-08       Impact factor: 7.094

2.  Cytokine expression in human labial minor salivary gland epithelial cells in health and disease.

Authors:  P C Fox; M Brennan; P Di Sun
Journal:  Arch Oral Biol       Date:  1999-05       Impact factor: 2.633

3.  T(H)1 cytokines are produced in labial salivary glands in Sjögren's syndrome, but also in healthy individuals.

Authors:  Y T Konttinen; P Kemppinen; H Koski; T F Li; M Jumppanen; J Hietanen; S Santavirta; T Salo; A Larsson; M Hakala; T Sorsa
Journal:  Scand J Rheumatol       Date:  1999       Impact factor: 3.641

4.  Balancing the Th1/Th2 concept in multiple sclerosis.

Authors:  J D Laman; E J Thompson; L Kappos
Journal:  Immunol Today       Date:  1998-11

5.  Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjögren's syndrome.

Authors:  R A Ajjan; R S McIntosh; E A Waterman; P F Watson; C D Franklin; C M Yeoman; A P Weetman
Journal:  Br J Rheumatol       Date:  1998-02

6.  Correlation between protein and mRNA abundance in yeast.

Authors:  S P Gygi; Y Rochon; B R Franza; R Aebersold
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Augmented levels of macrophage and Th1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis.

Authors:  W Mustafa; J Zhu; G Deng; A Diab; H Link; L Frithiof; B Klinge
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

8.  Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus.

Authors:  M Funauchi; S Ikoma; H Enomoto; A Horiuchi
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

9.  Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease.

Authors:  J J Lafaille; F V Keere; A L Hsu; J L Baron; W Haas; C S Raine; S Tonegawa
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

10.  T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice.

Authors:  S V Pakala; M O Kurrer; J D Katz
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

View more
  71 in total

Review 1.  Immunopathogenesis of Sjögren's syndrome.

Authors:  Andrea T Borchers; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

Review 2.  Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.

Authors:  M R Kok; B J Baum; P P Tak; S R Pillemer
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13.

Authors:  C S De Paiva; J K Raince; A J McClellan; K P Shanmugam; S B Pangelinan; E A Volpe; R M Corrales; W J Farley; D B Corry; D-Q Li; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-12-22       Impact factor: 7.313

Review 4.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

Review 5.  Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.

Authors:  Shivaram Selvam; Padmaja B Thomas; Sarah F Hamm-Alvarez; Joel E Schechter; Douglas Stevenson; Austin K Mircheff; Melvin D Trousdale
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

Review 6.  A conspicuous role for B cells In Sjögren's syndrome.

Authors:  Pierre Youinou; Valérie Devauchelle; Pascal Hutin; Rozenn Le Berre; Alain Saraux; Jacques-Olivier Pers
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 7.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

8.  A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion.

Authors:  Hyunjoo Lee; Shabirul Haque; Jennifer Nieto; Joshua Trott; John K Inman; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

9.  Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1/Th2 immune balance in peripheral blood in patients with primary Sjogren's syndrome.

Authors:  Guo-lin Wu; Tian-yi Li; Yong-sheng Fan; Guo-you Yu; Jiu Chen
Journal:  Chin J Integr Med       Date:  2013-08-24       Impact factor: 1.978

10.  Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.

Authors:  Cintia S De Paiva; Cindy S Hwang; John D Pitcher; Solherny B Pangelinan; Ehsan Rahimy; Wei Chen; Kyung-Chul Yoon; William J Farley; Jerry Y Niederkorn; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  Rheumatology (Oxford)       Date:  2009-12-09       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.